Single Use Bioreactors Market Industry Trends and Global Forecasts to 2035: Over 400 Patents Filed for Single-Use Bioreactors, Reflecting Growing Industry Innovation - ResearchAndMarkets.com

The "Single Use Bioreactors Market Industry Trends and Global Forecasts to 2035, by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, Application Area, End-users and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.

The global single use bioreactors market is estimated to grow from USD 1.3 billion in the current year to USD 6.6 billion by 2035, at a CAGR of 15% during the forecast period, till 2035.

Over the years, the adoption of single-use bioreactors is rising in the biopharmaceutical industry. This is primarily driven by various factors, such as cost benefits, ease of use, high throughput, simple sterilization, and contamination management. Moreover, with single-use technology, it is very easy to scale up operations without having to invest heavily in additional infrastructure. Such systems have a low footprint, are easy to transport and made up of regulatory approved materials, such as ethylene-vinyl acetate, polycarbonate, polyethylene, and polystyrene. As a result, single-use systems are preferred over conventional stainless-steel bioreactors. In fact, single-use technologies are anticipated to be adopted by ~90% of the biopharmaceutical industry over the coming years. Further, given the advantages offered by this technology, including operational flexibility, several academic institutes have also started to adopt these technologies.

Additionally, the implementation of single use systems in small scale R&D activities in the field of recombinant protein therapeutics, monoclonal antibody-based products, and cell-based products is likely to present an opportunity to the stakeholders engaged in the development of single-use bioreactors. In light of all these developments, the single-use bioreactors industry is likely to witness significant growth in the foreseen future.

Single Use Bioreactors Market: Key Insights

The report delves into the current state of the single use bioreactors market and identifies potential growth opportunities within the industry.

Some key findings from the report include:

• Currently, over 60 companies claim to offer more than 260 cutting-edge single-use bioreactors in order to cater to the rising demand for biopharmaceuticals, across the globe.
• The market is primarily characterized by the presence of well-established players that offer single-use bioreactors for processing of various cell cultures used for the production of different types of biologics.
• In pursuit of gaining a competitive edge, single-use bioreactor manufacturers are upgrading their existing capabilities and enhancing their product portfolios to achieve better, cost-effective and faster biomanufacturing.
• The growing interest of biologic manufacturers in single-use bioreactors is evident from the rise in partnership activity; more than 50% of the deals were inked specifically for stirred tank bioreactors.
• To cater to the increasing demand for biologics, a number of players have stepped up to introduce innovative and advance single-use bioreactors, establishing a strong brand position.
• Over 400 patents have been filed / granted for single-use bioreactors by various industry and non-industry players to protect the intellectual property generated within this field.
• The single-use bioreactors market is projected to grow at a CAGR of ~17% to 2035; the forecasted opportunity is likely to be distributed across different scales of operation, types of bioreactors and types of cell cultures.
• The growing demand for different types of biologics is anticipated to drive the growth of single-use bioreactors market; Asia-Pacific is anticipated to be the fastest growing region.

Single Use Bioreactors Market: Key Segments

Currently, Stirred Tank Bioreactors Occupies the Largest Share of the Single Use Bioreactors Market

• Based on the type of bioreactor, the market is segmented into stirred tank bioreactors, wave induced bioreactors and other bioreactors. At present, stirred tank bioreactors hold the maximum share within the single use bioreactors market. This trend is likely to remain the same in the near future.

Commercial Scale Segment is the Fastest Growing Segment of the Single Use Bioreactors Market During the Forecast Period

• Based on the scale of operation, the market is segmented into preclinical / clinical and commercial scale. While the preclinical / clinical scale accounts for a relatively higher market share, it is worth highlighting that commercial scale is expected to witness substantial market growth in the coming years.

Mammalian Segment is Likely to Dominate the Single Use Bioreactors Market During the Forecast Period

• Based on the type of cell culture, the market is segmented into mammalian, insect, microbial, viral, plant and bacterial. At present, the mammalian segment holds the maximum share of the single use bioreactors market. This trend is likely to remain the same in the forthcoming years.

Currently, Monoclonal Antibodies Occupy the Largest Share of the Single Use Bioreactors Market

• Based on the type of biologics synthesized, the market is segmented into vaccine, monoclonal antibody, recombinant protein, stem cell, cell therapy, and gene therapy. At present, monoclonal antibodies hold the maximum share of the single use bioreactors market. It is worth highlighting that single use bioreactors market for cell therapies is likely to grow at a relatively higher CAGR, during the forecast period.

Cancer Research Segment is Likely to Dominate the Single Use Bioreactors Market During the Forecast Period

• Based on the application area, the market is segmented into cancer research, stem cell research, tissue engineering / regenerative medicine, drug discovery / toxicity testing and others. Currently, the cancer research segment holds the maximum share within the single use bioreactors market. This trend is likely to remain the same in the forthcoming years.

Biopharmaceutical / Pharmaceutical Industries are Likely to Dominate the Single Use Bioreactors Market During the Forecast Period

• Based on the end-users, the market is segmented into biopharmaceutical / pharmaceutical industries, academic / research institutes. At present, the biopharmaceutical / pharmaceutical industry holds the maximum share of the single use bioreactors market. This trend is likely to remain the same in the forthcoming years.

North America Accounts for the Largest Share of the Market

• Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa. It is worth highlighting that, over the years, the market in Asia-Pacific is expected to grow at a higher CAGR.

Some Key Players in the Single Use Bioreactors Market include:

• Applikon Biotechnology
• Biolinx Labsystems
• Celartia
• Cell Culture Company
• Cellexus
• Cercell
• CESCO Bioengineering
• Cytiva
• Eppendorf
• Merck Millipore
• Pall Corporation
• PBS Biotech
• PerfuseCell
• ProlifeCell
• Sartorius Stedim Biotech
• Solaris Biotech
• Synthecon
• Thermo Fisher Scientific

Key Questions Answered in this Report

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What kind of partnership models are commonly adopted by industry stakeholders?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

4.1. Chapter Overview

4.2. Single-use Bioreactors: Overall Market Landscape

4.3. List of Single-use Bioreactor Manufacturers

4.4. Leading Manufacturers: Analysis by Number of Products

5. KEY INSIGHTS

5.1. Chapter Overview

5.2. Analysis by Company Size and Location of Headquarters

5.3. Analysis by Company Size and Type of Single-use Bioreactor

5.4. Analysis by Type of Single-use Bioreactor and Mode of Operation

5.5. Analysis by Type of Single-use Bioreactor and Type of Biologics Synthesized

5.6. Analysis by Scale of Operation, Type of Cell Culture and Type of Biologics Synthesized

5.7. Analysis by Location of Headquarters

6. COMPANY COMPETITIVENESS ANALYSIS

7. SINGLE-USE BIOREACTOR MANUFACTURERS IN NORTH AMERICA: COMPANY PROFILES

Leading Players based in North America

• Celartia
• Cell Culture Company
• Cytiva
• Merck Millipore
• Pall Corporation
• PBS Biotech
• Synthecon
• Thermo Fisher Scientific

8. SINGLE-USE BIOREACTOR MANUFACTURERS IN EUROPE, ASIA-PACIFIC AND REST OF THE WORLD: COMPANY PROFILES

Leading Players based in Europe, Asia-Pacific and Rest of the World

• Applikon Biotechnology
• Cellexus
• CerCell
• Eppendorf
• PerfuseCell
• ProlifeCell
• Sartorius Stedim Biotech
• Solaris Biotech

Leading Players based in Asia-Pacific and Rest of the World

• Biolinx Labsystems
• CESCO Bioengineering

9. PARTNERSHIPS AND COLLABORATIONS

10. PRODUCT COMPETITIVENESS ANALYSIS

11. BRAND POSITIONING ANALYSIS

• Pall Corporation
• Biolinx Labsystems
• Eppendorf
• Solaris Biotech
• Sartorius Stedim Biotech
• Applikon Biotechnology
• Cercell

12. PATENT ANALYSIS

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

14. CASE STUDY: KEY TECHNOLOGICAL INNOVATIONS IN THE SINGLE-USE BIOREACTORS INDUSTRY

15. SWOT ANALYSIS

16. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS

17. CONCLUSION

18. EXECUTIVE INSIGHTS

• Membio
• Distek
• Refine Technology
• CerCell
• CelVivo

For more information about this report visit https://www.researchandmarkets.com/r/rvm2ng

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250421656903/en/